These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
214 related articles for article (PubMed ID: 34014280)
1. Synergic effect of atorvastatin and ambrisentan on sinusoidal and hemodynamic alterations in a rat model of NASH. Bravo M; Raurell I; Barberá A; Hide D; Gil M; Estrella F; Salcedo MT; Augustin S; Genescà J; Martell M Dis Model Mech; 2021 May; 14(5):. PubMed ID: 34014280 [TBL] [Abstract][Full Text] [Related]
2. Restoration of liver sinusoidal cell phenotypes by statins improves portal hypertension and histology in rats with NASH. Bravo M; Raurell I; Hide D; Fernández-Iglesias A; Gil M; Barberá A; Salcedo MT; Augustin S; Genescà J; Martell M Sci Rep; 2019 Dec; 9(1):20183. PubMed ID: 31882668 [TBL] [Abstract][Full Text] [Related]
3. Pivotal role of liver sinusoidal endothelial cells in NAFLD/NASH progression. Miyao M; Kotani H; Ishida T; Kawai C; Manabe S; Abiru H; Tamaki K Lab Invest; 2015 Oct; 95(10):1130-44. PubMed ID: 26214582 [TBL] [Abstract][Full Text] [Related]
4. Simvastatin ameliorates liver fibrosis via mediating nitric oxide synthase in rats with non-alcoholic steatohepatitis-related liver fibrosis. Wang W; Zhao C; Zhou J; Zhen Z; Wang Y; Shen C PLoS One; 2013; 8(10):e76538. PubMed ID: 24098525 [TBL] [Abstract][Full Text] [Related]
5. Notch-triggered maladaptation of liver sinusoidal endothelium aggravates nonalcoholic steatohepatitis through endothelial nitric oxide synthase. Fang ZQ; Ruan B; Liu JJ; Duan JL; Yue ZS; Song P; Xu H; Ding J; Xu C; Dou GR; Wang L Hepatology; 2022 Sep; 76(3):742-758. PubMed ID: 35006626 [TBL] [Abstract][Full Text] [Related]
7. Atorvastatin lowers portal pressure in cirrhotic rats by inhibition of RhoA/Rho-kinase and activation of endothelial nitric oxide synthase. Trebicka J; Hennenberg M; Laleman W; Shelest N; Biecker E; Schepke M; Nevens F; Sauerbruch T; Heller J Hepatology; 2007 Jul; 46(1):242-53. PubMed ID: 17596891 [TBL] [Abstract][Full Text] [Related]
8. Endothelial group IVA phospholipase A Kawashita E; Ozaki T; Ishihara K; Kashiwada C; Akiba S Life Sci; 2022 Apr; 294():120355. PubMed ID: 35093339 [TBL] [Abstract][Full Text] [Related]
9. Silymarin suppresses hepatic stellate cell activation in a dietary rat model of non-alcoholic steatohepatitis: analysis of isolated hepatic stellate cells. Kim M; Yang SG; Kim JM; Lee JW; Kim YS; Lee JI Int J Mol Med; 2012 Sep; 30(3):473-9. PubMed ID: 22710359 [TBL] [Abstract][Full Text] [Related]
10. FXR agonist obeticholic acid reduces hepatic inflammation and fibrosis in a rat model of toxic cirrhosis. Verbeke L; Mannaerts I; Schierwagen R; Govaere O; Klein S; Vander Elst I; Windmolders P; Farre R; Wenes M; Mazzone M; Nevens F; van Grunsven LA; Trebicka J; Laleman W Sci Rep; 2016 Sep; 6():33453. PubMed ID: 27634375 [TBL] [Abstract][Full Text] [Related]
11. Hepatitis C virus core protein induces dysfunction of liver sinusoidal endothelial cell by down-regulation of silent information regulator 1. Sun LJ; Yu JW; Shi YG; Zhang XY; Shu MN; Chen MY J Med Virol; 2018 May; 90(5):926-935. PubMed ID: 29350417 [TBL] [Abstract][Full Text] [Related]
12. Quantitative real-time measurement of endothelin-1-induced contraction in single non-activated hepatic stellate cells. Dohi N; Yamaguchi M; Hase R; Suzuki R; Wakabayashi Y; Nishiyama R; Saito SY; Ishikawa T PLoS One; 2021; 16(8):e0255656. PubMed ID: 34343209 [TBL] [Abstract][Full Text] [Related]
15. Atorvastatin and Vitamin E Accelerates NASH Resolution by Dietary Intervention in a Preclinical Guinea Pig Model. Klaebel JH; Skjødt M; Skat-Rørdam J; Rakipovski G; Ipsen DH; Schou-Pedersen AMV; Lykkesfeldt J; Tveden-Nyborg P Nutrients; 2019 Nov; 11(11):. PubMed ID: 31752351 [TBL] [Abstract][Full Text] [Related]
16. Ambrisentan and tadalafil synergistically relax endothelin-induced contraction of rat pulmonary arteries. Liang F; Yang S; Yao L; Belardinelli L; Shryock J Hypertension; 2012 Mar; 59(3):705-11. PubMed ID: 22311911 [TBL] [Abstract][Full Text] [Related]
17. AMPK agonist AICAR ameliorates portal hypertension and liver cirrhosis via NO pathway in the BDL rat model. Hu L; Su L; Dong Z; Wu Y; Lv Y; George J; Wang J J Mol Med (Berl); 2019 Mar; 97(3):423-434. PubMed ID: 30721324 [TBL] [Abstract][Full Text] [Related]
18. A Nitric Oxide-Donating Statin Decreases Portal Pressure with a Better Toxicity Profile than Conventional Statins in Cirrhotic Rats. Rodríguez S; Raurell I; Torres-Arauz M; García-Lezana T; Genescà J; Martell M Sci Rep; 2017 Jan; 7():40461. PubMed ID: 28084470 [TBL] [Abstract][Full Text] [Related]
19. Activation of Insulin-PI3K/Akt-p70S6K Pathway in Hepatic Stellate Cells Contributes to Fibrosis in Nonalcoholic Steatohepatitis. Cai CX; Buddha H; Castelino-Prabhu S; Zhang Z; Britton RS; Bacon BR; Neuschwander-Tetri BA Dig Dis Sci; 2017 Apr; 62(4):968-978. PubMed ID: 28194671 [TBL] [Abstract][Full Text] [Related]
20. Pleiotropic Effects of Statins in the Light of Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis. Ahsan F; Oliveri F; Goud HK; Mehkari Z; Mohammed L; Javed M; Althwanay A; Rutkofsky IH Cureus; 2020 Sep; 12(9):e10446. PubMed ID: 33072455 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]